Abstract:The entry of human immunodeficiency virus (HIV) into cells depends on a sequential interaction of the gp120 envelope glycoprotein with the cellular receptors CD4 and members of the chemokine receptor family. The CC chemokine receptor CCR5 is such a receptor for several chemokines and a major coreceptor for the entry of R5 HIV type-1 (HIV-1) into cells. Although many studies focus on the interaction of CCR5 with HIV-1, the corresponding interaction sites in CCR5 and gp120 have not been matched. Here we used an approach combining protein structure modeling, docking and molecular dynamics simulation to build a series of structural models of the CCR5 in complexes with gp120 and CD4. Interactions such as hydrogen bonds, salt bridges and van der Waals contacts between CCR5 and gp120 were investigated. Three snapshots of CCR5–gp120–CD4 models revealed that the initial interactions of CCR5 with gp120 are involved in the negatively charged N-terminus (Nt) region of CCR5 and positively charged bridging sheet region of gp120. Further interactions occurred between extracellular loop2 (ECL2) of CCR5 and the base of V3 loop regions of gp120. These interactions may induce the conformational changes in gp120 and lead to the final entry of HIV into the cell. These results not only strongly support the two-step gp120–CCR5 binding mechanism, but also rationalize extensive biological data about the role of CCR5 in HIV-1 gp120 binding and entry, and may guide efforts to design novel inhibitors. Figure Three structural models of CCR5 in complex with gp120–CD4. These represent snapshots of different intermediates of the complex that characterize the dynamic interaction process of CCR5 with gp120. The ribbon diagram shows gp120 in red , the two N-terminal domains of CD4 in yellow , and CCR5 in blue . The Nt, ECL1, 2, and 3 in CCR5, as well as the bridging sheet and V3 loop base of gp120 are labeled. Model I shows that Nt begins to interact with the bridging sheet, the ECLs of CCR5 do not interact with gp120 and there is a big gap between them. It is a snapshot of the initial recognition of CCR5 with gp120. Model III shows that ECL2 begins to interact with the V3 loop base in addition to the interaction between Nt and the bridging sheet. It is a snapshot of the transition state of the binding process. Model II shows the full interaction between CCR5 and gp120. More residues within Nt interact with the bridging sheet, ECL2 and ECL3 interact with the V3 base loop and bridging sheet, respectively. It is a snapshot of a "fusion-active" state prior to virus entry. The interaction intensities between CCR5 and gp120 are model I<model III<model II

Role of the V2, V3, and CD4-binding Domains of GP120 in Curdlan Sulfate Neutralization Sensitivity of HIV-1 During Infection of T Lymphocytes.

Systematic review of the efficacy and safety of colorectal stents

The N-Terminal Srcr-Sid Domain of Gp-340 Interacts with Hiv Type 1 Gp120 Sequences and Inhibits Viral Infection

The Molecular Mechanism of Two Coreceptor Binding Site Antibodies X5 and 17b Neutralizing HIV-1: Insights from molecular dynamics simulation.

Clinically applicable magnetic-labeling of natural killer cells for MRI of transcatheter delivery to liver tumors: preclinical validation for clinical translation.

Sulfated Polysaccharide, Curdlan Sulfate, Efficiently Prevents Entry/Fusion and Restricts Antibody-Dependent Enhancement of Dengue Virus Infection In Vitro: A Possible Candidate for Clinical Application

The Glycan‐mediated Mechanism on the Interactions of Gp120 with CD4 and Antibody: Insights from Molecular Dynamics Simulation

Understanding the molecular mechanism of the broad and potent neutralization of HIV-1 by antibody VRC01 from the perspective of molecular dynamics simulation and binding free energy calculations

Pharmacodynamics of 2-{4-[(1E)-1-(Hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridine-4-yl)-1H-pyrazol-1-yl}ethan-1-ol (GDC-0879), a Potent and Selective B-Raf Kinase Inhibitor: Understanding Relationships between Systemic Concentrations, Phosphorylated Mitogen-Activated Protein Kinase Kinase 1 Inh

Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV.

Identification of human immunodeficiency virus type 1 (HIV-1) gp120-binding sites on scavenger receptor cysteine rich 1 (SRCR1) domain of gp340

Theoretical Studies on the Interactions and Interferences of HIV-1 Glycoprotein Gp120 and Its Coreceptor CCR5

Identification of an N-linked glycosylation in the C4 region of HIV-1 envelope gp120 that is critical for recognition of neighboring CD4 T cell epitopes.

Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies

HIV-1 gp120-CXCR4 recognition probed with synthetic nanomolar affinity D-peptides containing fragments of gp120 V3 loop

CCR6 Mediates the Intracellular HIV Inhibitory Activity of Human Beta-Defensin 2

Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies

CXCR4 Recognition by L- and D-Peptides Containing the Full-Length V3 Loop of HIV-1 Gp120.

Soluble Hla-G Inhibits Myeloid Dendritic Cell Function In Hiv-1 Infection By Interacting With Leukocyte Immunoglobulin-Like Receptor B2

Role Of Cxcr4 Internalization In The Anti-Hiv Activity Of Stromal Cell-Derived Factor-1 Alpha Probed By A Novel Synthetically And Modularly Modified-Chemokine Analog

N-linked Glycosylation in the CXCR4 N-terminus Inhibits Binding to HIV-1 Envelope Glycoproteins.